MAM
BIIB icon

McCarthy Asset Management’s Biogen BIIB Stock Holding History

McCarthy Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4
Closed -$1K – 329
2021
Q3 		$1K Hold
4
– – ﹤0.01% 315
2021
Q2 		$1K Hold
4
– – ﹤0.01% 379
2021
Q1 		$1K Hold
4
– – ﹤0.01% 332
2020
Q4 		$1K Buy
+4
New +$1.03K ﹤0.01% 306

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

McCarthy Asset Management's BIIB Position: Q4 2021 in Review

McCarthy Asset Management sold out of Biogen (BIIB) in Q4 2021, closing a stake of 4 shares — an estimated $1K sold.

McCarthy Asset Management first reported a position in BIIB in Q4 2020 and held it in 4 quarters. The position peaked at $1K in Q3 2021. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • McCarthy Asset Management reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • McCarthy Asset Management sold 4 Biogen shares in Q4 2021, an estimated $1K.
  • McCarthy Asset Management first reported a position in Biogen in Q4 2020 and held it in 4 quarters.
  • McCarthy Asset Management's Biogen position peaked at $1K in Q3 2021.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on McCarthy Asset Management's 13F filing for Q4 2021, filed 7 Feb 2022.